FR2866571B1 - USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING. - Google Patents

USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Info

Publication number
FR2866571B1
FR2866571B1 FR0401700A FR0401700A FR2866571B1 FR 2866571 B1 FR2866571 B1 FR 2866571B1 FR 0401700 A FR0401700 A FR 0401700A FR 0401700 A FR0401700 A FR 0401700A FR 2866571 B1 FR2866571 B1 FR 2866571B1
Authority
FR
France
Prior art keywords
sulfate
ezbone
chondroid
heparin
inventor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0401700A
Other languages
French (fr)
Other versions
FR2866571A1 (en
Inventor
Philippe Zanchetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0401700A priority Critical patent/FR2866571B1/en
Publication of FR2866571A1 publication Critical patent/FR2866571A1/en
Application granted granted Critical
Publication of FR2866571B1 publication Critical patent/FR2866571B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
FR0401700A 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING. Expired - Fee Related FR2866571B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0401700A FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0401700A FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Publications (2)

Publication Number Publication Date
FR2866571A1 FR2866571A1 (en) 2005-08-26
FR2866571B1 true FR2866571B1 (en) 2007-09-21

Family

ID=34833936

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0401700A Expired - Fee Related FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Country Status (1)

Country Link
FR (1) FR2866571B1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8017139B2 (en) 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US8236342B2 (en) 2007-08-03 2012-08-07 Zimmer, Inc. Multi-polymer hydrogels
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281265B1 (en) * 2005-11-24 2008-08-16 Bioiberica, S.A. COMPOSITIONS FOR THE TREATMENT OF ARTROSIS.
ES2304886B1 (en) * 2007-04-13 2009-11-11 Bioiberica, S.A. "COMPOSITIONS TO NUTRIR THE ARTICULATIONS".
WO2011071453A1 (en) * 2009-12-09 2011-06-16 Agency For Science, Technology And Research Glycosaminoglycan mixtures
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (en) * 1994-07-19 1994-07-19 Astra Ab Hard tissue stimulant with electricity
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
FR2811229B1 (en) * 2000-07-04 2003-08-01 Ifremer USE OF A POLYSACCHARIDE EXCRETED BY THE VIBRIO DIABOLICUS SPECIES IN BONE HEALING

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017139B2 (en) 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US8236342B2 (en) 2007-08-03 2012-08-07 Zimmer, Inc. Multi-polymer hydrogels
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces

Also Published As

Publication number Publication date
FR2866571A1 (en) 2005-08-26

Similar Documents

Publication Publication Date Title
FR2866571B1 (en) USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.
EP2305269A3 (en) Immunemodulating oligosaccharides
ITRM20030210A1 (en) PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY
DK1660458T3 (en) 2,4-Pyrimidine diamines useful in the treatment of neoplastic diseases, inflammatory disorders and disorders of the immune system.
EP1809661A4 (en) Human interferon-beta mutein
EP1561760A3 (en) Low molecular weight heparin salt with thriethanolamine
DE602005027883D1 (en) 2-O, 3-O DESULFATED HEPARIN FOR THE TREATMENT OF HEPARINE-INDUCED THROMBOCYTOPENY (HIT)
WO2008028100A3 (en) Posable toy and method of forming
GB2427863B (en) Heparin-Binding Protein Having Heparan Sulfate Sugar Chain Attached Thereto Process For Producing The Same And Medicinal Composition Containing The Same
ES2190535T3 (en) LECTIN COMPOSITIONS AND USE OF THE SAME.
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
ITMI20000665A0 (en) GLYCOSAMINOGLICANS DERIVED FROM THE K5 POLYSACCHARIDE WITH HIGH ANTICOAGULANT AND ANTITHROMBOTIC ACTIVITY AND PROCESS FOR THEIR PREPARATION
UA35209U (en) Method for extension of human life
WO2007059874A3 (en) Compositions for the treatment of osteoarthritis and to nourish the synovial fluid
PL375088A1 (en) Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
BR0316059A (en) Use of fosinopril to reduce cardiovascular events in dialysis patients
ATE407682T1 (en) DIETARY SUPPLEMENT COMPOSITION FOR PROMOTING IRON ABSORPTION
NZ501366A (en) Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas
Sun et al. Research of China Economic Parks Based on Complexity Chaos Theory
BR8203352U (en) Round pool table with hexagonal tables
BR8102420U (en) Toys for public squares, playgrounds and the like made from modules
RU2002104397A (en) THERAPY FOR THE TREATMENT OF ARTHROSIS
CN2357773Y (en) Intelligence magic ball
FR2798670B1 (en) LACTICAL BACTERIES TRANSFORMED TO PROVIDE THEM WITH BREATHING METABOLISM, AND LEAVES INCLUDING SAID BACTERIA
CA2446615A1 (en) Nutritional composition for the treatment of connective tissue

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20191006